Exchange: OTC·Updated 02:29 PM EST

About MEDXF

About

Medexus Pharmaceuticals, Inc. engages in the licensing, acquisition, development, and commercialization of specialty pharmaceutical products in the United States and Canada. The company focuses on therapeutic areas including hematology, hematology-oncology, rheumatology, and allergy. Its principal commercial products include GRAFAPEX, IXINITY, Rasuvo, Metoject, Rupall, and Trecondyv. The company was founded in 2003 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
90

Frequently Asked Questions

Advertisement|Remove ads.